XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 143 $ 315
Accounts receivable, net of allowance for credit losses of $27 and $30 as of September 30, 2023 and December 31, 2022, respectively 1,281 1,195
Inventories 184 192
Prepaid expenses and other current assets 207 196
Total current assets 1,815 1,898
Property, plant and equipment, net 1,830 1,766
Operating lease right-of-use assets 607 585
Goodwill 7,732 7,220
Intangible assets, net 1,219 1,092
Investments in equity method investees 130 132
Other assets 149 144
Total assets 13,482 12,837
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 1,157 1,396
Current portion of long-term debt 304 2
Current portion of long-term operating lease liabilities 157 153
Total current liabilities 1,618 1,551
Long-term debt 3,946 3,978
Long-term operating lease liabilities 505 489
Other liabilities 874 812
Commitments and contingencies
Redeemable noncontrolling interest 76 77
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2023 and December 31, 2022; 162 shares issued as of both September 30, 2023 and December 31, 2022 2 2
Additional paid-in capital 2,302 2,295
Retained earnings 8,711 8,290
Accumulated other comprehensive loss (20) (21)
Treasury stock, at cost; 50 and 51 shares as of September 30, 2023 and December 31, 2022, respectively (4,570) (4,673)
Total Quest Diagnostics stockholders' equity 6,425 5,893
Noncontrolling interests 38 37
Total stockholders' equity 6,463 5,930
Total liabilities and stockholders' equity $ 13,482 $ 12,837